Effectiveness of paliperidone palmitate one-month long-acting injection in obese vs. non-obese patients

被引：0
作者：
Dorflinger, Charles [1 ]
LeHew, Colleen [1 ]
Carey, Heather [1 ]
Roche-Desilets, Jennifer [1 ]
Burant, Christopher J. [2 ,3 ]
机构：
[1] VA Northeast Ohio Healthcare Syst, Pharm Dept, 10701 East Blvd, Cleveland, OH 44106 USA
[2] VA Northeast Ohio Healthcare Syst, Geriatr Res Educ & Clin Ctr, 10701 East Blvd, Cleveland, OH 44106 USA
[3] Case Western Reserve Univ, Frances Payne Bolton Sch Nursing, 10900 Euclid Ave, Cleveland, OH 44106 USA
来源：
COMPREHENSIVE PSYCHIATRY | 2021年 / 111卷
关键词：
MEDICATION ADHERENCE; SCHIZOPHRENIA; PREVALENCE;
D O I：
10.1016/j.comppsych.2021.152269
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页数：4
相关论文
共 50 条
  • [41] A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
    Liu, Jie
    Wang, Qian
    Su, Lei
    Yang, Limin
    Zou, Lianyong
    Bai, Ludong
    BMC PSYCHIATRY, 2022, 22 (01)
  • [42] Effectiveness and Predictors of Discontinuation of Aripiprazole Long-acting Injection A 12-Month Naturalistic Cohort Study
    Aftab, Romaisa
    Pereira, Marco
    Hewitt, Jed
    Whale, Richard
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2021, 41 (04) : 478 - 483
  • [43] The Effectiveness of Risperidone Long-acting Injection in Oral Antipsychotic Non-Adherent Patients with Schizophrenia: A Retrospective Study
    Akkaya, Cengiz
    Sarandol, Asli
    Kotan, Vahap Ozan
    Cangur, Sengul
    Aydin, Ayseguel
    Kirli, Selcuk
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 19 (03): : 255 - 262
  • [44] Clinical outcomes of paliperidone long-acting injection in patients with schizophrenia: a 1-year retrospective cohort study
    Hsue-Wei Chan
    Chin-Yu Huang
    Yung-Chieh Yen
    BMC Psychiatry, 21
  • [45] Clinical outcomes of paliperidone long-acting injection in patients with schizophrenia: a 1-year retrospective cohort study
    Chan, Hsue-Wei
    Huang, Chin-Yu
    Yen, Yung-Chieh
    BMC PSYCHIATRY, 2021, 21 (01)
  • [46] Importance of Long-Acting Injectable Antipsychotic Preparation, Administration, and Injection Site Tolerability: A Focus on Paliperidone Palmitate Once-Every-6-Months Formulation
    Krozer, Steven
    Johnston, Karen L.
    Najarian, Dean
    Wang, Steven
    Fua, Sherry
    Kern Sliwa, Jennifer
    Lopena, Oliver
    PERSPECTIVES IN PSYCHIATRIC CARE, 2023, 2023
  • [47] Number needed to treat and number needed to harm with paliperidone palmitate relative to long-acting haloperidol, bromperidol, and fluphenazine decanoate for treatment of patients with schizophrenia
    Gopal, Srihari
    Berwaerts, Joris
    Nuamah, Isaac
    Akhras, Kasem
    Coppola, Danielle
    Daly, Ella
    Hough, David
    Palumbo, Joseph
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2011, 7 : 93 - 101
  • [48] A health economics study of long-acting injectable once-monthly paliperidone palmitate in schizophrenia: a one-year mirror-image study in China
    Jie Liu
    Qian Wang
    Lei Su
    Limin Yang
    Lianyong Zou
    Ludong Bai
    BMC Psychiatry, 22
  • [49] Impact of paliperidone palmitate one-month formulation on relapse prevention in patients with schizophrenia: A post-hoc analysis of a one-year, open-label study stratified by medication adherence
    Si, Tianmei
    Li, Nan
    Lu, Huafei
    Cai, Shangli
    Zhuo, Jianmin
    Correll, Christoph U.
    Zhang, Lili
    Feng, Yu
    JOURNAL OF PSYCHOPHARMACOLOGY, 2018, 32 (06) : 691 - 701
  • [50] Cost effectiveness of long-acting risperidone injection versus alternative antipsychotic agents in patients with schizophrenia in the USA
    Natalie Christine Edwards
    Julie C. Locklear
    Marcia F. T. Rupnow
    Ronald J. Diamond
    PharmacoEconomics, 2005, 23 : 75 - 89
12345